"In May, Healthy Vision Month, the National Eye Institute (NEI) calls on Americans to make their vision a priority by taking the necessary steps to protect vision, prevent vision loss, and make the most of the vision they may have remaining."...
Voltaren Ophthalmic is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery.
DOSAGE AND ADMINISTRATION
One drop of Voltaren Ophthalmic should be applied to the affected eye, 4 times daily beginning 24 hours after cataract surgery and continuing throughout the first 2 weeks of the postoperative period.
Corneal Refractive Surgery
One or two drops of Voltaren Ophthalmic should be applied to the operative eye within the hour prior to corneal refractive surgery. Within 15 minutes after surgery, one or two drops should be applied to the operative eye and continued 4 times daily for up to 3 days.
Voltaren Ophthalmic 0.1% (1 mg/mL) Sterile Solution is supplied in a low density polyethylene (LDPE) white bottle with a LDPE Dropper Tip and Polypropylene grey closure. The 5 mL fill is supplied in a 10 mL size bottle.
Bottles of 5 mL NDC 0065-xxxx-xx
Store at 15°C to 25°C (59° to 77°F).
Dispense in original, unopened container only.
Alcon Made in Canada. Manufactured for: Alcon Laboratories, Inc. 6201 South Freeway Fort Worth, TX 76134 USA.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/29/2012
Additional Voltaren Ophthalmic Information
- Voltaren Ophthalmic Drug Interactions Center: diclofenac sodium opht
- Voltaren Ophthalmic Side Effects Center
- Voltaren Ophthalmic in detail including Side Effects and Drug Images
- Voltaren Ophthalmic Overview including Precautions
- Voltaren Ophthalmic FDA Approved Prescribing Information including Dosage
Voltaren Ophthalmic - User Reviews
Voltaren Ophthalmic User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.